Effect of crude extract and essential oil of Cordia verbenacea in experimental periodontitis in rats

Brazilian Journal of Oral Sciences

Volumn 11, Issue 1, 2012, Pages 42-46

  Ribeiro, Fernanda Vieira ^a   Barrella, Guilherme Emerson ^a   Casarin, Renato Corrêa Viana ^a   Cirano, Fabiano Ribeiro ^a   Foglio, Mary Ann ^b   Pimentel, Suzana Peres ^a  

^a PAULISTA UNIVERSITY   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Alveolar bone loss; Cordia; Inflaqmmation; Periodontitis

Indexed keywords

EID: 84862167981     PISSN: 16773217     EISSN: 16773225     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. De Souza AP, da Silva RA, da Silva MAD, Catanzaro-Guimarães SA, Line SRP. Matrix metalloproteinases: the most important pathway involved with periodontal destruction. Braz J Oral Sci. 2005; 4: 884-90.
2. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol. 2003; 8: 12-37.
3. Gurgel BC, Duarte PM, Nociti FH Jr, Sallum EA, Casati MZ, Sallum AW, et al. Impact of an anti-inflammatory therapy and its withdrawal on the progression of experimental periodontitis in rats. J Periodontol. 2004; 75: 1613-8.
4. Holzhausen M, Spolidorio DM, Muscará MN, Hebling J, Spolidorio LC. Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats. J Periodontal Res. 2005; 40: 208-11.
5. Queiroz-Junior CM, Pacheco CM, Maltos KL, Caliari MV, Duarte ID, Francischi JN. Role of systemic and local administration of selective inhibitors of cyclo oxygenase 1 and 2 in an experimental model of periodontal disease in rats. J Periodontal Res. 2009; 44: 153-60.
6. Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001; 345: 433-42.
7. Calixto JB, Campos MM, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 2004; 70: 93-103.
8. Cai X, Li C, Du G, Cao Z. Protective effects of baicalin on ligature-induced periodontitis in rats. J Periodontal Res. 2008; 43: 14-21.
9. Toker H, Ozan F, Ozer H, Ozdemir H, Eren K, Yeler H. A morphometric and histopathologic evaluation of the effects of propolis on alveolar bone loss in experimental periodontitis in rats. J Periodontol. 2008; 79: 1089-94.
10. Botelho MA, Martins JG, Ruela RS, I R, Santos JA, Soares JB, et al. Protective effect of locally applied carvacrol gel on ligature-induced periodontitis in rats: a tapping mode AFM study. Phytother Res. 2009; 23: 1439-48.
11. Napimoga MH, Benatti BB, Lima FO, Alves PM, Campos AC, Pena-Dos-Santos DR, et al. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol. 2009; 9: 216-22.
12. Sertié JA, Woisky RG, Wiezel G, Rodrigues M. Pharmacological assay of Cordia verbenacea; Part 1. Anti-inflammatory activity and toxicity of the crude extract of the leaves. Planta Med. 1988; 54: 7-10.
13. Sertié JA, Basile AC, Panizza S, Oshiro TT, Azzolini CP, Penna SC. Pharmacological assay of Cordia verbenacea. III: Oral and topical antiinflammatory activity and gastrotoxicity of a crude leaf extract. J Ethnopharmacol. 1991; 31: 239-47.
14. Sertié JA, Woisky RG, Wiezel G, Rodrigues M. Pharmacological assay of Cordia verbenacea V: oral and topical anti inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. Phytomedicine. 2005; 12: 338-44.
15. Ticli FK, Hage LI, Cambraia RS, Pereira PS, Magro AJ, Fontes MR, et al. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction. Toxicon. 2005; 46: 318-27.
16. Passos GF, Fernandes ES, Da Cunha FM, Ferreira J, Pianowski LF, Campos MM, et al. Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from Cordia verbenacea. J Ethnopharmacol. 2007; 110: 323-33.
17. Roldão Ede F, Witaicenis A, Seito LN, Hiruma-Lima CA, Di Stasi LC. Evaluation of the antiulcerogenic and analgesic activities of Cordia verbenacea DC. (Boraginaceae). J Ethnopharmacol. 2008; 119: 94-8.
18. Fernandes MI, Gaio EJ, Oppermann RV, Rados PV, Rosing CK. Comparison of histometric and morphometric analyses of bone height in ligature-induced periodontitis in rats. Braz Oral Res. 2007; 21: 216-21.
19. Van Assche G, Rutgeerts P. Anti-TNF agents in Crohn's disease. Expert Opin Investig Drugs. 2000; 9: 103-11.
20. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol. 2002; 2: 364-71.
21. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest. 2001; 108: 15-23.
22. Murakami M, Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res. 2004; 43: 33-5.
23. Sertié JA, Basile AC, Panizza S, Matida AK, Zelnik R. Anti inflammatory activity and sub-acute toxicity of artemetin. Planta Med. 1990; 56: 36-40.
24. De Carvalho PM JR, Rodrigues RF, Sawaya AC, Marques MO, Shimizu MT. Chemical composition and antimicrobial activity of the essential oil of Cordiaverbenacea D.C. J Ethnopharmacol. 2004; 95: 297-301.
25. Michielin EM, Salvador AA, Riehl CA, Smânia A JR, Smânia EF, Ferreira SR. Chemical composition and antibacterial activity of Cordia verbenacea extracts obtained by different methods. Bioresour Technol. 2009; 100: 6615-23.
26. Bezerra MM, De Lima V, Alencar VB, Vieira IB, Brito GA, Ribeiro RA, et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol. 2000; 71: 1009-14.
27. Ng VW, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol. 1998; 69: 772-6.
28. Aras H, Ca{eth}layan F, Güncü GN, Berbero{eth}lu A, Kilinç K. Effect of systemically administered naproxen sodium on clinical parameters and myeloperoxidase and elastase-like activity levels in gingival crevicular fluid. J Periodontol. 2007; 78: 868-73.
29. Azoubel MC, Sarmento VA, Cangussú V, Azoubel E, Bittencourt S, Cunha FQ, et al. Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: short-term evaluation. J Periodontol. 2008; 79: 1719-25.
30. Emery P. Clinical implications of selective cyclooxygenase-2 inhibition. Scand J Rheumatol Suppl. 1996; 102: 23-88.